In previous studies associated with cancer progression, UBE2N mostly functioned on the activation/inactivation of cancer-related signaling pathways (e.g., MEK/FRA1/SOX10 and TAK1-p38 MAP kinase cascade) [25, 33]. Here, MAPK14 is linked to cancer.